Purpose: To examine whether 99m Tc(V)-DMSA could be used as a non-invasive measure of cancer cell proliferation.
Introduction
The ability to non-invasively detect and image cell growth and proliferation throughout the body has long been recognised to be of significant value in the diagnosis, staging and treatment of cancer. The expansion of a tumour mass is directly related to its growth fraction, which can be assessed by measuring DNA synthesis by following incorporation of [ 3 H] or [ 14 C] labelled thymidine. This is acceptable for in vitro model systems and in animals but as long lived beta emitters, neither radionuclide is suitable for imaging in humans. Thymidine also has the disadvantage that it is rapidly catabolised and produces large amounts of re-circulating labeled catabolites following administration [1] , reducing tumour-to-normal-tissue signaling during detection and imaging of tracer incorporation into DNA by kinetic modeling [2] .
Positron emission tomography (PET) has emerged as a very sensitive physiological, metabolic and molecular gamma ray detection technology that is used for imaging in many research and clinical applications but principally in oncology. For several decades the most commonly used PET tracer has been the cyclotron produced 2-[fluorine-18]Fluoro-2-deoxy-D-glucose ( 18 F-FDG). However, this is neither cell specific nor very appropriate for measurement of cell proliferation, besides which it has a short half-life of less than 2 h. Several non-catabolised thymidine analogues such as ([ 18 [3] [4] [5] [6] . However, incorporation of 18 F-FLT proceeds only to the triphosphate nucleoside step in the DNA synthetic pathway and not into DNA itself [7] . There are also some practical drawbacks of 18 F-FLT for identifying sites of proliferative activity or malignancy in the liver and bone marrow due to the presence of high background radioactivity, and interference with pelvic lesions due to its significant excretion into the urinary bladder [8] [9] [10] [11] .
The short half-life of PET tracers has also limited their use to centers equipped with an on-site cyclotron. The practical need for longer-lived tracers has been resolved by the use of technetium99m ( 99m Tc) . This radiotracer, is produced by a generator that is readily available in most hospital nuclear medicine departments and does not need an on-site cyclotron to produce it. It's half-life of 6 h is long enough to perform nuclear medicine tests and short enough to minimize radiation exposure to the patient. Thus 99m Tc is a very useful isotope that has been incorporated into many tumor imaging agents such as 99m Tc-hexakis-2-methoxyisobutylisonitrile (sestamibi; 99m Tc-MIBI), used to detect metastatic breast cancer [12] [13] . Pentavalent 99m Tc-dimercaptosuccinic acid ( 99m Tc(V)-DMSA) formed from labelling of meso-2,3-dimercaptosuccinic acid (DMSA) with 99m Tc under alkaline conditions, has been found to be a tumor-seeking agent. It was introduced to evaluate, image and manage medullary carcinoma of the thyroid [14] [15] . Also it has been reported to be useful in detecting many other types of cancers such as head and neck, soft tissue tumors [16] [17] , breast [12, 18] , brain [19] , lung [20] [21] , bone [22] , and particularly for metastatic and high-grade tumors [23] and both primary and metastatic carcinoma of the prostate [24] [25] and melanoma [26] .
Several reports from Papantoniou and colleagues [13, [27] [28] [29] suggest that in vivo 99m Tc(V)-DMSA uptake by breast lesions is related to proliferative activity, which is either directly related to tumor grade or to the mitotic activity.
In this study we have sought to determine whether 99m Tc(V)-DMSA uptake could be correlated with the rate of cell proliferation using an in vitro model system. Typically, attaching monolayer cultures undergo a lag phase followed by a period of rapid growth that then slows as the cells in the culturing vessel reach confluence. Confuency is the measure of % coverage of the culturing vessel. We measured 99m Tc(V)-DMSA uptake into several different cancer cell lines under these different conditions and compared this with assessment of other known proliferationassociated markers. 
Materials and Methods

Materials
Cell culture and culture media
Human breast cancer MCF-7, MDA-MB-231 and prostate cancer PC-3 cell lines were purchased from Cell Lines Service (CLS, Germany). pII is an estrogen receptor down-regulated transfected cell line derived from MCF-7 [30] . All cell lines were maintained in Advanced Dulbecco's Modified Eagle's Medium (Advanced DMEM) supplemented with 5% fetal bovine serum (FBS), 10,000 units/ml penicillin, 10,000 mg/ml streptomycin, 200 mM L-glutamine and non-essential amino acids. All cells were routinely incubated in a 37uC humidified incubator in an atmosphere of 5% CO 2 -95% air. For sub-culturing, cell monolayers were harvested with trypsin-EDTA. Cell counting was carried out using a haemocytometer (Assitent, Germany) and Cell Viability Analyzer (Beckmann Coulter Vi-cell TM XR, USA). For most experiments cells were seeded into 25 cm flasks and grown to 30%, 50% and 100% confluency. All experiments were repeated thrice and individual conditions were performed in triplicate each time.
We chose breast cancer cell lines as reports from Papantoniou and colleagues [13, [27] [28] [29] suggest that in vivo 99m Tc(V)-DMSA uptake by particularly early breast lesions is related to proliferative activity. The evidence for this is extensively discussed in a recent review [31] . Parameters that could indicate increased proliferative activity could be very useful in predicting the progression of atypical hyperplastic or in situ tumours. We selected a well established and extensively used endocrine sensitive line (MCF-7) (this has also been shown to express type III NaPi co-transporters) as well as one that is naturally endocrine resistant (MDA-MB-231) and one that has acquired resistance (pII) as a consequence of siRNA transfection-the latter two being more aggressive in terms of metastatic propensity. As our aim was to determine whether our hypothesis was generally applicable, we also chose another cell line derived from a different tissue (prostate-PC-3) that has been shown to exhibit significantly higher phosphocholine as well as glycerophosphocholine levels, i.e., increased phospholipid metabolism [32] [33] [34] [35] [36] .
Preparation of 99m Tc(V)-DMSA
The commercial meso-2,3-dimercaptosuccinic acid (DMSA) kit (Succimer), for the preparation of trivalent technetium-99m DMSA ( 99m Tc(III)-DMSA), was used here for the preparation of technetium-99m (V) complex with DMSA.
99m Tc(V)-DMSA complex was prepared by addition of sodium bicarbonate solution to the kit vial followed by the addition of 99m Tc-eluate (Na 99m TcO4, approximately 500 MBq). The reaction mixture reached a pH value of approximately 8 (as determined with pH indicator strips) and was then left for 15 min at room temperature. This value of pH indicates the optimum conversion to 99m Tc(V)-DMSA [37] [38] [39] [40] .
The efficiency of radiolabeling of DMSA was assessed by ascending thin-layer chromatography using Merck silica gel 60F (TLC-SG 60; Merck, Germany) and n-butanol:acetic acid:H 2 O (3:2:3) developing mixture. The retention factor (Rf) value for 99m Tc(V)-DMSA was 0.7 while for 99m Tc(III)-DMSA it was 0.1 giving a very clear separation [41] . The radiochemical purity was calculated as the percentage of 99m Tc(V)-DMSA relative to total activity on the plate. Typically we obtained efficiencies in excess of 95% conversion of 99m Tc(III)-DMSA to 99m Tc(V)-DMSA. The 99m Tc(V)-DMSA mixture was used within 3 h of preparation.
It has previously been reported [42] that almost all of the trivalent technetium-99m DMSA ( 99m Tc(III)-DMSA) remaining in the labeled preparation can be changed into 99m Tc(V)-DMSA by bubbling with pure oxygen. We therefore performed comparative uptake experiments using 99m Tc(V)-DMSA prepared with oxygen bubbling (100% oxygen) for 10 min or with no bubbling (0% oxygen). The 99m Tc(V)-DMSA was also used for in vivo imaging in patients showing significant uptake into breast tumors (data not presented).
Determination of 99m Tc(V)-DMSA uptake into cell cultures
All the cell lines were pulse labeled with 99m Tc(V)-DMSA (74 MBq/ml medium) for 60 min at 37uC. The culture medium was removed and counted to determine effluxed radioactivity using a dose calibrator (ATOMLAB 100, USA). The cell monolayers were rapidly washed three times with ice-cold phosphate buffered saline (PBS) and detached with 0.5 ml trypsin-EDTA followed by re-suspension in 5 ml of medium. The cells were centrifuged at 10,000 g for 5 min at 4uC and solubilized with 1% sodium dodecyl sulphate (SDS) in 10 mM sodium borate. The 99m Tc(V)-DMSA incorporated into the cellular lysate was counted as above.
Results were expressed as the total 99m Tc(V)-DMSA radioactivity uptake in megabecquerel (MBq) per mg of protein.
Effect of Na+-dependent phosphate cotransporter (NaPi) inhibitors
In other experiments, MCF-7 cells were grown to about 60-70% density in a 24 well plate. These were pretreated for either 99m Tc-(V)DMSA Assessment and Cell Proliferation 24 h or 48 h with 50 mM imatinib (prepared as a 10 mM stock solution in DMSO), or for 15 min with 5 mM and 10 mM phosphonoformic acid (PFA) prior to uptake determination of 99m Tc(V)-DMSA as described above.
Extraction of radio-labeled metabolites and lipids
The intracellular fate of the 99m Tc(V)-DMSA (phospholipid synthesis) was determined by extraction of cell pellets with chloroform/methanol tris (hydroxymethyl) aminomethane buffer solvent system as described by Bligh and Dyer [43] and Al-Saeedi et al [34] . Cell pellets were re-suspended in 0.2 ml PBS in eppendorf tubes to which 0.5 ml of methanol and 0.25 ml of chloroform was added and left at 4uC for 20 min. After this period, further 0.25 ml chloroform was added to the suspension, followed by 0.5 ml 10 mM Tris buffer (pH 7) with thorough mixing. After centrifugation at 1000 g for 10 min at 4uC, the lower (lipid) phase was removed to a fresh tube and the upper (aqueous) phase was re-extracted by addition of a further 0.5 ml of chloroform, followed by centrifugation. Then both lipid and aqueous phases were counted for 99m Tc(V)-DMSA content. H]thymidine (51.8 MBq/ml of medium per flask) for 1 h at 37uC in order to assess DNA synthesis. Cells were washed thrice with ice cold PBS, trypsinized and centrifuged at 10,000 g for 5 min at 4uC. Cell pellets were suspended with ice cold PBS and left on ice for 15 min before centrifugation. Pellets were resuspended in 1 ml of 4% trichloroacetic acid (TCA) (Fluka, UK) at 4uC and again centrifuged. Washes were repeated in 4% TCA at 4uC until the radioactivity in the supernatant was reduced to background level. To solubilise the DNA (acid-insoluble fraction), the pellet was resuspended in 0.5 ml of 4% TCA and heated to 90uC for 1 h. Then the cell debris was removed by centrifugation and washed with 0.5 ml of 4% TCA. The resulting supernatants and pellets were pooled, then suspended with Ultima Gold TM scintillation fluid (PerkinElmer, USA) and counted in a Beckman LS 6000 TA liquid scintillation counter (Beckman, USA).
RNA extraction and measurement of gene expression
Total cellular RNA was extracted from frozen cell pellets of MCF-7, MDA-MB-231, pII and PC-3 cells using the RNeasy Plus Mini kit (Qiagen, USA) according to the manufacturer's protocol, quantitated by spectrometry and checked for integrity by standard agarose gel electrophoresis. cDNA synthesis was performed with 2 mg RNA in 20 ml using the High Capacity Reverse Transcription Kit from Applied Biosystems. Quantitative realtime polymerase chain reaction (PCR) was performed on 1 ul cDNA using a standard multiplexed Taqman PCR kit protocol (manufacturer proprietary primer/probe mixes: FAM dye-labeled TaqMan/VIC dye-labeled TaqMan (FAM/VIC) labelled target was combined with JOE dye-labeled probe, labelled normaliser actin gene oligonucleotides) to determine expression of proliferating cell nuclear antigen (PCNA), Ki67. The 20 ml reactions were performed in a 96-well plate on an Applied Biosystems 7500HT Sequence Detection System by incubation at 95uC for 10 min, followed by 40 cycles of 95uC for 15 s and 60uC for 1 min. The raw threshold cycle (CT) values were analyzed by the 2 (2DDCt) method using the spreadsheet developed by Pfaffl [44] to determine normalized expression ratios of target genes. PCR products were also confirmed by electrophoresis on 1% agarose gel.
Flow cytometry
For each line, cells were grown to 3 different densities in triplicate flasks to determine the S phase proportion by 2 dimensional flow cytometry analysis. For this, cells were washed twice with ice cold PBS and harvested by trypsinization. Cell pellets were fixed by adding 5 ml of ice cold 70% ethanol by constant stirring and then left overnight at -20uC. Prior to flow cytometry, fixed cells were washed with PBS. The cell number was adjusted to 10 6 /ml. RNAse (Qiagen, USA) (1.4 ml) was added to cells which were incubated at 37uC for 15 min. This was followed by addition of 200 ml of propidium iodide (PI). Flow cytometry was performed with a Cytomics FC-500 Beckmann Coulter instrument with analysis using FC 500 Beckmann CXP software.
Protein determination
Protein content was determined using the Bradford protein assay kit (Bio Rad, USA) after solubilisation with 1 M NaOH and neutralization with 1 M HCl. Bovine serum albumin was used as standard.
Statistical analysis
Charting and statistics were performed using Excel and Graphpad Prismsoftware. All data are expressed as mean 6 standard deviation (mean6SD) unless otherwise stated. One way analysis of variance (ANOVA) was used to determine the statistical differences between groups.
Results
Uptake of 99m Tc(V)-DMSA
Initial experiments were conducted with MCF-7 cells to optimize conditions. Cells were seeded into 25 cm flasks to achieve densities of 30, 50, 70, 80, 90 and 100% confluency. This was done by determining the number of cells needed to achieve 100% confluency after two days of growth and seeding appropriately reduced numbers of cells for the other densities. Uptake of 99m Tc(V)-DMSA was then measured after 10 and 60 min of incubation. The data illustrated in Fig. 1 shows that, with both time periods, the relative rate of uptake (per number of cells) was greatest at the lowest cell density and decreased with increasing cell density. For all further experiments we used incubation times of 60 min (longer times were also attempted but due to the short isotope decay time this did not offer additional advantage) and cell densities of 30, 50 and 100%. Experiments were also performed using 99m Tc(V)-DMSA that had been prepared with oxygen bubbling but showed no significant difference, and as this was also 99m Tc-(V)DMSA Assessment and Cell Proliferation a technically difficult procedure to maintain sterility, its use was discontinued. Fig. 2 shows 99m Tc(V)-DMSA uptake for each of the four cell lines used in this study. For comparison, the uptake at 30% confluency was assigned as 1 and uptake at other densities was expressed relative to this. In all cases the relative rate of uptake was inversely related to cell density. The intracellular fate of the 99m Tc(V)-DMSA was determined in MCF-7 cells by partitioning the pelleted cellular material, following the uptake experiment, into aqueous and lipid soluble phases (phospholipid synthesis). Both phases were counted for 99m Tc(V)-DMSA content. Less than 5% of the label appeared in the lipid fraction indicating that almost all of the 99m Tc(V)-DMSA that enters the cell remains unbound to lipid during the time of the experiment.
Uptake of [methyl-3 H]thymidine
This was determined under the same conditions as for 99m Tc(V)-DMSA uptake and the results are shown in Fig. 3 . With all four lines, relative uptake significantly decreased with increasing cell density.
S-phase distribution
Flow cytometry was used to determine the proportion of cells in S-phase at the different densities. Significant decrease was noted as cells reached 100% confluency, in all the four cell lines (Fig. 4) .
Effect of imatinib and phosphonoformic acid on 99m Tc(V)-DMSA uptake MCF-7 cells were exposed to either imatinib for 24 h and 48 h or to PFA for 15 min prior to measuring uptake of 99m Tc(V)-DMSA. Uptake was significantly decreased in the presence of imatinib by about 70% after the 24 h exposure (data not shown) and by about 60% after the 48 h exposure as compared with untreated controls, indicating that 99m Tc(V)-DMSA enters the cell mainly through transporters rather than simple diffusion (Fig. 5) . Tc(V)-DMSA uptake for each of the four cell lines used in this study. For comparison, the uptake at 30% confluency (black solid rectangular) was assigned as 1 and uptake at 50% (grey solid rectangular) and 100% (hatched bars) densities was expressed relative to this. Histobars represent mean 6 SD of 3 replicates. One way ANOVA showed significant differences with p = 0.01 (*), p,0.0001 (**), p = 0.001 (***). doi:10.1371/journal.pone.0054361.g002 This was further confirmed by the inhibition of uptake by PFA, a direct competitive inhibitor of NaPi cotransporters.
Effect of cell density on expression of proliferation markers
PCNA and Ki-67 expression determined by Taqman quantitative PCR showed significant decrease as cells reached 100% confluency in all the four cell lines (Fig. 6) . Expression in 50% confluent MCF-7 however was higher than at 30% and then decreased at 100% for both genes. This was not seen with the other cell lines.
Fluorine-18-FluoroDeoxy Glucose ( 18 F-FDG) Uptake 18 F-FDG uptake was determined in MCF-7 cells grown to different confluencies and was found to be the same at all densities.
Effect of extracellular Na
+ on 99m Tc(V)-DMSA uptake 99m Tc(V)-DMSA uptake was decreased by approximately 50%, by replacing sodium with N-methyl-D-glucamine in the culture medium prior to measuring uptake.
Discussion
In agreement with many studies reporting that 99m Tc(V)-DMSA prepared under alkaline conditions showed increased uptake into a variety of tumors [14 15, 17, 19, 27] we observed active uptake into several cell lines in vitro.
This radiotracer is not only used as a diagnostic tool but even further as a therapeutic agent. Pentavalent rhenium-188 dimercaptosuccinic acid ( 188 Re(V)-DMSA) is a beta-emitting analogue of 99m Tc(V)-DMSA, a tracer that is taken up into a variety of tumors and bone metastases that is used on a therapeutic scale for cancer therapy [45] [46] [47] [48] . For example, the treatment with 188 Re(V)-DMSA in cases of advanced disease with osseous and soft tissue metastatic spread could be considered if these lesions are depicted by breast and whole-body 99m Tc(V)-DMSA scintigraphy [31] . In some reports, 188 Re(V)-DMSA was loaded with poly(-lactic-co-glycolic)acid microspheres for targeted radiotherapy and for the delivery of a radiation dose to tumors [31, 47] .
The technetium is pentavalent and coordinated by an oxoligand and four thiolate sulfurs of two DMSA ligands. [20, 26] and the group of Papantoniou have performed several studies on breast lesions, extensively reviewed earlier this year [31] . In this publication it is also mentioned that a protocol for use of 99m Tc(V)-DMSA as a guide for therapeutic administration of 188 Re(V)-DMSA for advanced breast cancer is underway at the Vince Institute of Nuclear Sciences in Belgrade. This agent has advantages over currently employed PET radiopharmaceuticals. It is safe, cheap and readily available in many nuclear medicine centers, and can be prepared Tc-(V)DMSA uptake into MCF-7. Cells were grown to 60-70% confluency and then exposed to either 50 mM imatinib for 48 h or to PFA for 15 min prior to determining tracer uptake as described in Methods. Each histobar represents mean 6 SD of 3 replicates. * denotes significant difference from control with p,0.001. doi:10.1371/journal.pone.0054361.g005 as an in house radiopharmaceutical. Unlike for example the more commonly used imaging agent 18 F-FDG, there is no need for a cyclotron to produce it so it would be useful for medical centers that have no or limited access to such facilities for generating the current range of PET tracers. PET is not currently well-established in Kuwait; this study could provide some justification for considering a future trial to examine the utility of 99m Tc(V)-DMSA as a nuclear medicine marker that can be synthesized locally without the need for an expensive cyclotron.
The label was predominantly found in the aqueous fraction of cell extracts indicating actual uptake into the cell rather than immediate incorporation into membrane or other phospholipid. The comparative rates of uptake differed between the three breast and one prostate line, being higher in the more aggressive estrogen receptor negative MDA-MB-231 and pII lines. Interestingly, MCF-7 do not show invasive characteristics in in vitro assays [52] and PC-3 is an androgen independent prostate cell line which although displaying metastatic potential originates from a tumour type that is characteristically slower growing. In all cases however, we observed an inverse correlation between 99m Tc(V)-DMSA uptake and cell density. It is generally the case that the growth rate of tumors slows as they increase in size, mainly as a result of poorer vascularization and necrosis at the centre. As this is an important consideration in the design of chemotherapeutic strategies, information regarding growth rates can be clinically useful, as well indicating prognosis. Our simple in vitro model aims to simulate slow and faster growing groups of cells and the results suggest that the imaging tracer 99m Tc(V)-DMSA can provide additional information in this respect.
It is considered that 99m Tc(V)-DMSA utilizes the type III NaPi co-transporters [35] [36] as phosphonoformic acid, a competitive inhibitor of NaPi co-transport, also affects 99m Tc(V)-DMSA uptake. Our data is consistent with studies showing that this transport is largely Na + dependent. Activated platelet-derived growth factor receptor (PDGF-R) pathway is involved in this transport mechanism. The addition of the PDGF-R inhibitor, imatinib, at least partially inhibited 99m Tc(V)-DMSA in our study after both 24 and 48 h of exposure to the drug, an agreement with previous studies. This drug has also been shown previously to reduce expression of these transporters [53] [54] [55] [56] [57] . Several studies reported that imatinib mesylate, a small molecule inhibiting the PDGF-R tyrosine kinase, suppressed NaPi co-transporter expression sufficiently during the time-frame of the experiment, the 24 h pre-incubation [32, 58, 59] .
A recent study on U87-MG glioblastoma cells investigated an issue with obvious clinical implications, the ability of 99m Tc(V)-DMSA to trace the antiproliferative effects of imatinib mesylate [60] . Cells treated with imatinib for 48 h showed significant decreases in proliferation, invasion, migration and PDGF-R expression.
99m Tc(V)-DMSA cellular uptake studies showed that the specificaction of imatinib on PDGF-R signal pathway, in the human glioblastoma cell line U87-MG, could be followed by radioactive tracer. Furthermore, strong correlations between cellular 99m Tc(V)-DMSA uptake and the effect of imatinib therapy on U87-MG proliferation, invasion and migration were obtained, likewise for 99m Tc(V)-DMSA uptake and PDGF-R expression [60] . Besides, imatinib mesylate was initiated to treat the temozolomide-refractory tumor [55, 61] .
The uptake of [methyl-3 H]thymidine into cells and its subsequent incorporation into DNA is a common measure of cell proliferation. We have shown that its uptake into all four of our cell lines parallels that of 99m Tc(V)-DMSA, decreasing with increasing cell density. Similarly, flow cytometry showed that the proportion of cells in s-phase was also inversely correlated with cell density. One study has reported that 99m Tc(V)-DMSA brain scintitomography is a plausible non-invasive measure of glioblastoma proliferation and therapy response [58] . Recent papers have demonstrated that in vivo 99m Tc(V)-DMSA uptake has been correlated with the proliferation index measured by Ki-67 expression and phosphorylated focal adhesion kinase [19, 29, 59] . We found that expression of Ki-67 as well as of PCNA, another common proliferation marker, inversely correlated with cell density.
As a comparison, we also measured uptake of 18 F-FDG, a commonly used imaging tracer, and found that unlike 99m Tc(V)-DMSA, its transport into cells was unrelated to proliferation rate, as has previously been reported [62] .
In summary, we have demonstrated carrier mediated uptake of 99m Tc(V)-DMSA into 4 independent cancer cell lines and shown that this correlates well with proliferation rate using cells under conditions of fast and slow growth. The model has been validated with measurement of several parameters commonly accepted as markers of proliferation rate.
Conclusion
Our data indicates that it would be worthwhile to conduct further studies to examine the extent of 99m Tc(V)-DMSA uptake into tumors with respect to their rates of growth so that it may have an additional use beyond detection/localization of tumours.
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